Conservative Management of HSIL in Patients With Future Pregnancy Aspiration

Recruiting Observational Study
Cervical Intraepithelial Neoplasia Squamous Intraepithelial Lesions of the Cervix Uterine Cervical Dysplasia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Conservative management of high-grade squamous intraepithelial lesions (HSILs) seems safe and justified in young women (\<30 years), but evidence is insufficient on whether it is also advisable for older women. This study will be conducted to analyze spontaneous HSIL regression rates in women of reproductive age and establish whether conservative HSIL management could be safely recommended to wom…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Reproductive age and aspirations of future pregnancies * Acceptance of conservative management * Commitment to attend scheduled follow-up visits * Colposcopy with transformation zone (ZT) type 1 or 2 (fully visible squamous-columnar union) with lesion with grade 2 changes visi…
Contacts

Natalia Teixeira, MD, Ph.D.

+34604311873

nteixeira@santpau.cat

CONTACT

Nerea Nerea, MD

+34935537041

nluqui@santpau.cat

CONTACT